Hydrophobicity regulates self-assembly behavior of binding-induced fibrillogenesis peptides
Source abstract
Abstract
Binding-induced fibrillogenesis (BIF) peptides have a promising future in biomedicine due to the processiblity in situ in vivo, which bind to a specific trigger and in situ self-assemble into nanofibrous structures (BIF process) with excellent physical/biological functions. Alkyl chains in BIF peptides as hydrophobic tails have an important effect on self-assembly behaviors of BIF peptides. Herein, BIF peptides (trigger: Ca2+ or integrin) with different hydrophobic alkyl chains are designed to explore the influence of hydrophobicity on self-assembly behaviors of BIF peptides (Abbreviation as BIF4, BIF8, and BIF16 for 4, 8, 16 carbons of alkyl chains). It is found that BIF peptides with weak hydrophobicity (BIF4) do not form fibrous structure upon binding to Ca2+, but in nanoparticle formulation. While with strong hydrophobicity, BIF16 initially self-assemble into nanoparticles, which further bind to Ca2+ and self-assemble into nanofibers with a β-sheet conformation. As a result, when incubated with HUVECs overexpressing integrins on surfaces, BIF4 were internalized as nanoparticles without BIF process, but BIF16 performed BIF process and attached on cell surfaces. This study provides experimental evidences of the hydrophobicity effect on self-assembly behavior of BIF peptides and directs applications of BIF peptides with controllable self-assembly
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Luminescence and Fluorescent Materials · Polydiacetylene-based materials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. A self-destructive nanosweeper that captures and clears amyloid β-peptides10.1038/s41467-018-04255-z ↗
2. Self-assembled peptide-based nanomaterials for biomedical imaging and therapy10.1002/adma.201703444 ↗
3. Transformable nanomaterials as an artificial extracellular matrix for inhibiting tumor invasion and metastasis10.1021/acsnano.7b00781 ↗
4. Supramolecular materials: self-organized nanostructures10.1126/science.276.5311.384 ↗
5. Functional supramolecular polymers10.1126/science.1205962 ↗
6. Self-assembly and mineralization of peptide-amphiphile nanofibers10.1126/science.1063187 ↗
7. Challenges and opportunities of nanomedicines in clinical translation10.15212/bioi-2021-0016 ↗
8. Engineered nanomedicines for tumor vasculature blockade therapy10.1002/wnan.1691 ↗
9. Polymer-mediated penetration-independent cancer therapy10.1021/acs.biomac.9b01263 ↗
10. Smart transformable nanoparticles for enhanced tumor theranostics10.1063/5.0061530 ↗
11. Infection microenvironment-responsive multifunctional peptide coated gold nanorods for bimodal antibacterial applications10.1016/j.colcom.2021.100379 ↗
12. The effect of increasing hydrophobicity on the self-assembly of amphipathic β-sheet peptides10.1039/b904439f ↗
13. Tuning β-sheet peptide self-assembly and hydrogelation behavior by modification of sequence hydrophobicity and aromaticity10.1021/bm200510k ↗
14. Beta-sheet-forming, self-assembled peptide nanomaterials towards optical, energy, and healthcare applications10.1002/smll.201500169 ↗
15. Peptide-based nanomaterials: self-assembly, properties and applications
16. Self-assembled peptide fibrils with pH-sensitive reversible surface-active properties10.1016/j.colcom.2020.100325 ↗
17. Self-assembly behavior of peptide amphiphiles (PAs) with different length of hydrophobic alkyl tails10.1016/j.colsurfb.2010.07.027 ↗
18. Amphiphilic self-assembly peptides: rational strategies to design and delivery for drugs in biomedical applications10.1016/j.colsurfb.2021.112040 ↗
19. Amphiphilic peptides as novel nanomaterials: design, self-assembly and application10.2147/IJN.S166403 ↗
20. Self-assembling amphiphilic peptides10.1002/psc.2633 ↗
21. Self-assembly of amphiphilic peptides10.1039/c0sm01218a ↗
22. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials10.1073/pnas.072699999 ↗
23. Peptide self-assembly: thermodynamics and kinetics10.1039/C6CS00176A ↗
24. Live cells process exogenous peptide as fibronectin fibrillogenesis in vivo10.31635/ccschem.020.201900117 ↗
25. Peptide-based nanoparticles mimic fibrillogenesis of laminin in tumor vessels for precise embolization10.1021/acsnano.0c02110 ↗
26. A monotargeting peptidic network antibody inhibits more receptors for anti-angiogenesis10.1021/acsnano.1c02194 ↗
27. Detection of amyloid-β by Fmoc-KLVFF self-assembled fluorescent nanoparticles for Alzheimer’s disease diagnosis10.1016/j.cclet.2020.09.009 ↗
28. Protective effects of wogonin against Alzheimer's disease by inhibition of amyloidogenic pathway10.1155/2017/3545169 ↗
29. The role of β3-integrins in tumor angiogenesis: context is everything10.1016/j.ceb.2011.03.014 ↗
30. Mechanism of thioflavin T binding to amyloid fibrils10.1016/j.jsb.2005.06.006 ↗
31. Secondary nucleation in amyloid formation10.1039/C8CC02204F ↗
32. Mechanism of amyloid protein aggregation and the role of inhibitors10.1515/pac-2018-1017 ↗
33. Bio-inspired metal ions regulate the structure evolution of self-assembled peptide-based nanoparticles10.1039/C6NR03580A ↗
34. Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin
35. Hierarchical self-assembly of a β-amyloid peptide derivative10.1039/C2TB00105E ↗
36. On the role of sidechain size and charge in the aggregation of αβ42 with familial mutations10.1073/pnas.1803539115 ↗
37. Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates10.1126/sciadv.aau3112 ↗
38. Gold nanorods based multicompartment mesoporous silica composites as bioagents for highly efficient photothermal therapy10.1016/j.jcis.2019.04.051 ↗
39. In situ construction of ligand nano-network to integrin αvβ3 for angiogenesis inhibition10.1016/j.cclet.2020.04.006 ↗
40. An innovative pre-targeting strategy for tumor cell specific imaging and therapy10.1039/C5NR03862F ↗
41. Purpurin modulates tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model10.1007/s00018-019-03312-0 ↗
42. Host materials transformable in tumor microenvironment for homing theranostics10.1002/adma.201605869 ↗